Equities research analysts expect HMS Holdings Corp (NASDAQ:HMSY) to report sales of $143.71 million for the current fiscal quarter, according to Zacks Investment Research. Six analysts have made estimates for HMS’s earnings. The highest sales estimate is $145.10 million and the lowest is $142.60 million. HMS posted sales of $141.43 million in the same quarter last year, which suggests a positive year over year growth rate of 1.6%. The firm is expected to issue its next earnings report before the market opens on Friday, May 3rd.
According to Zacks, analysts expect that HMS will report full-year sales of $647.64 million for the current year, with estimates ranging from $641.40 million to $658.00 million. For the next financial year, analysts expect that the business will report sales of $701.83 million, with estimates ranging from $685.90 million to $741.00 million. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side research analysts that cover HMS.
HMS (NASDAQ:HMSY) last released its quarterly earnings results on Friday, February 22nd. The business services provider reported $0.28 EPS for the quarter, topping analysts’ consensus estimates of $0.25 by $0.03. HMS had a net margin of 9.19% and a return on equity of 14.21%. The company had revenue of $155.80 million for the quarter, compared to the consensus estimate of $155.84 million. During the same period in the previous year, the firm earned $0.24 EPS. HMS’s revenue was up 4.9% on a year-over-year basis.
A number of analysts have commented on HMSY shares. Zacks Investment Research upgraded shares of HMS from a “hold” rating to a “buy” rating and set a $33.00 price target on the stock in a research report on Tuesday, January 22nd. BidaskClub downgraded shares of HMS from a “buy” rating to a “hold” rating in a research report on Wednesday, March 6th. ValuEngine downgraded shares of HMS from a “strong-buy” rating to a “buy” rating in a research report on Monday, December 17th. Cantor Fitzgerald reiterated a “hold” rating and issued a $34.00 target price on shares of HMS in a report on Friday, February 22nd. Finally, William Blair reiterated an “outperform” rating on shares of HMS in a report on Thursday, March 14th. Four analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. HMS currently has an average rating of “Buy” and a consensus price target of $33.50.
HMSY stock opened at $30.26 on Tuesday. HMS has a 52 week low of $17.11 and a 52 week high of $38.15. The stock has a market cap of $2.58 billion, a price-to-earnings ratio of 36.02, a P/E/G ratio of 2.85 and a beta of 1.61. The company has a debt-to-equity ratio of 0.34, a quick ratio of 4.40 and a current ratio of 4.40.
In related news, insider Meredith W. Bjorck sold 7,954 shares of the business’s stock in a transaction that occurred on Thursday, April 11th. The shares were sold at an average price of $30.60, for a total value of $243,392.40. Following the sale, the insider now directly owns 51,755 shares in the company, valued at approximately $1,583,703. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Meredith W. Bjorck sold 2,362 shares of the business’s stock in a transaction that occurred on Monday, April 15th. The stock was sold at an average price of $30.10, for a total transaction of $71,096.20. Following the completion of the sale, the insider now owns 51,755 shares in the company, valued at $1,557,825.50. The disclosure for this sale can be found here. Insiders sold a total of 1,018,795 shares of company stock worth $35,023,853 over the last quarter. Insiders own 4.54% of the company’s stock.
Several institutional investors have recently added to or reduced their stakes in HMSY. FMR LLC purchased a new position in shares of HMS in the third quarter worth approximately $27,949,000. Franklin Resources Inc. purchased a new position in shares of HMS in the third quarter worth approximately $295,000. Allianz Asset Management GmbH increased its position in shares of HMS by 22.1% in the third quarter. Allianz Asset Management GmbH now owns 95,860 shares of the business services provider’s stock worth $3,146,000 after acquiring an additional 17,380 shares in the last quarter. Riverhead Capital Management LLC increased its position in shares of HMS by 19.2% in the third quarter. Riverhead Capital Management LLC now owns 9,320 shares of the business services provider’s stock worth $306,000 after acquiring an additional 1,500 shares in the last quarter. Finally, BlueMountain Capital Management LLC purchased a new position in shares of HMS in the third quarter worth approximately $146,000. 95.44% of the stock is currently owned by institutional investors and hedge funds.
HMS Company Profile
HMS Holdings Corp., through its subsidiaries, provides cost containment solutions in the United States healthcare marketplace. It provides coordination of benefits services to government and commercial healthcare payers and sponsors to coordinate benefits for claims; and payment integrity services that ensure healthcare claims billed are accurate and appropriate, as well as offers care management and consumer engagement solutions.
Featured Story: Growth and Income Funds
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for HMS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HMS and related companies with MarketBeat.com's FREE daily email newsletter.